KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Retained Earnings (2016 - 2025)

Historic Retained Earnings for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to $12.8 billion.

  • Gilead Sciences' Retained Earnings rose 1582.23% to $12.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $12.8 billion, marking a year-over-year increase of 1582.23%. This contributed to the annual value of $11.5 billion for FY2024, which is 2948.36% down from last year.
  • Latest data reveals that Gilead Sciences reported Retained Earnings of $12.8 billion as of Q3 2025, which was up 1582.23% from $11.3 billion recorded in Q2 2025.
  • Over the past 5 years, Gilead Sciences' Retained Earnings peaked at $16.9 billion during Q3 2021, and registered a low of $10.7 billion during Q1 2024.
  • For the 5-year period, Gilead Sciences' Retained Earnings averaged around $14.1 billion, with its median value being $15.1 billion (2022).
  • As far as peak fluctuations go, Gilead Sciences' Retained Earnings skyrocketed by 2329.86% in 2021, and later plummeted by 3080.24% in 2024.
  • Quarter analysis of 5 years shows Gilead Sciences' Retained Earnings stood at $16.3 billion in 2021, then fell by 3.9% to $15.7 billion in 2022, then rose by 3.93% to $16.3 billion in 2023, then dropped by 29.48% to $11.5 billion in 2024, then increased by 11.55% to $12.8 billion in 2025.
  • Its last three reported values are $12.8 billion in Q3 2025, $11.3 billion for Q2 2025, and $10.9 billion during Q1 2025.